Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Breier, A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 175 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Barancik, M; Bohacova, V; Kvackajova, J; Hudecova, S; Krizanova, O; Breier, A
      SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    2. Meehan, K; Zhang, F; David, S; Tohen, M; Janicak, P; Small, J; Koch, K; Rizk, R; Walker, D; Tran, P; Breier, A
      A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutelyagitated patients diagnosed with bipolar mania

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    3. Kvackajova-Kisucka, J; Barancik, M; Breier, A
      Drug transporters and their role in multidrug resistance of neoplastic cells

      GENERAL PHYSIOLOGY AND BIOPHYSICS
    4. Clark, WS; Street, JS; Feldman, PD; Breier, A
      The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease

      JOURNAL OF CLINICAL PSYCHIATRY
    5. Breier, A
      A new era in the pharmacotherapy of psychotic disorders - Introduction

      JOURNAL OF CLINICAL PSYCHIATRY
    6. Elman, I; Goldstein, DS; Adler, CM; Shoaf, SE; Breier, A
      Inverse relationship between plasma epinephrine and testosterone levels during acute glucoprivation in healthy men

      LIFE SCIENCES
    7. Wright, P; Birkett, M; David, SR; Meehan, K; Ferchland, I; Alaka, KJ; Saunders, JC; Krueger, J; Bradley, P; San, L; Bernardo, M; Reinstein, M; Breier, A
      Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    8. Edgell, ET; Andersen, SW; Johnstone, BM; Dulisse, B; Revicki, D; Breier, A
      Olanzapine versus risperidone - A prospective comparison of clinical and economic outcomes in schizophrenia

      PHARMACOECONOMICS
    9. Breier, A; Buchanan, RW; Irish, D; Carpenter, WT
      Clozapine treatment of outpatients with schizophrenia: Outcome and long-term response patterns

      PSYCHIATRIC SERVICES
    10. Kestler, LP; Malhotra, AK; Finch, C; Adler, C; Breier, A
      The relation between dopamine D-2 receptor density and personality: Preliminary evidence from the NEO personality inventory-revised

      NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY
    11. Carpenter, WT; Breier, A; Buchanan, RW; Kirkpatrick, B; Shepard, P; Weiner, E
      Mazindol treatment of negative symptoms

      NEUROPSYCHOPHARMACOLOGY
    12. Adler, CM; Elman, I; Weisenfeld, N; Kestler, L; Pickar, D; Breier, A
      Effects of acute metabolic stress on striatal dopamine release in healthy volunteers

      NEUROPSYCHOPHARMACOLOGY
    13. Bertolino, A; Breier, A; Callicott, JH; Adler, C; Mattay, VS; Shapiro, M; Frank, JA; Picker, D; Weiberger, DR
      The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    14. Bohacova, V; Kvackajova, J; Barancik, M; Drobna, Z; Breier, A
      Glutathione S-transferase does not play a role in multidrug resistance of L1210/VCR cell line

      PHYSIOLOGICAL RESEARCH
    15. Hamilton, SH; Edgell, ET; Revicki, DA; Breier, A
      Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    16. Breier, A; Ziegelhoffer, A
      "Lysine is the Lord", thought some scientists in regard to the group interacting with fluorescein isothiocyanate in ATP-binding sites of P-type ATPases - But, is it not cysteine?

      GENERAL PHYSIOLOGY AND BIOPHYSICS
    17. Breier, A; Uhrik, B
      Prof. Jozef Zachar, 1925-2000 - Obituary

      GENERAL PHYSIOLOGY AND BIOPHYSICS
    18. Ziegelhoffer, A; Kjeldsen, K; Bundgaard, H; Breier, A; Vrbjar, N; Dzurba, A
      Na,K-ATPase in the myocardium: Molecular principles, functional and clinical aspects

      GENERAL PHYSIOLOGY AND BIOPHYSICS
    19. Watabe, H; Endres, CJ; Breier, A; Schmall, B; Eckelman, WC; Carson, RE
      Measurement of dopamine release with continuous infusion of [C-11]raclopride: Optimization and signal-to-noise considerations

      JOURNAL OF NUCLEAR MEDICINE
    20. Gomez, JC; Sacristan, JA; Hernandez, J; Breier, A; Carrasco, PR; Saiz, CA; Carbonell, EF
      The safety of olanzapine compared with other antipsychotic drugs: Results of an observational prospective study in patients with schizophrenia (EFESOstudy)

      JOURNAL OF CLINICAL PSYCHIATRY
    21. David, SR; Taylor, CC; Kinon, BJ; Breier, A
      The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia

      CLINICAL THERAPEUTICS
    22. Breier, A; Drobna, Z; Docolomansky, P; Barancik, M
      Cytotoxic activity of several unrelated drugs on L1210 mouse leukemic cellsublines with P-glycoprotein (PGP) mediated multidrug resistance (MDR) phenotype. A QSAR study

      NEOPLASMA
    23. Tohen, M; Jacobs, TG; Grundy, SL; McElroy, SL; Banov, MC; Janicak, PG; Sanger, T; Risser, R; Zhang, F; Toma, V; Francis, J; Tollefson, GD; Breier, A
      Efficacy of olanzapine in acute bipolar mania - A double-blind, placebo-controlled study

      ARCHIVES OF GENERAL PSYCHIATRY
    24. Purdon, SE; Jones, BDW; Stip, E; Labelle, A; Addington, D; David, SR; Breier, A; Tollefson, GD
      Neuropsychological change in early phase schizophrenia during 12 months oftreatment with olanzapine, risperidone, or haloperidol

      ARCHIVES OF GENERAL PSYCHIATRY
    25. Street, JS; Clark, WS; Gannon, KS; Cummings, JL; Bymaster, FP; Tamura, RN; Mitan, SJ; Kadam, DL; Sanger, TM; Feldman, PD; Tollefson, GD; Breier, A
      Olanzapine treatment of psychotic and behavioral symptoms in patients withAlzheimer disease in nursing care facilities - A double-blind, randomized,placebo-controlled trial

      ARCHIVES OF GENERAL PSYCHIATRY
    26. Kosmidis, MH; Breier, A; Fantie, BD
      Avoidance learning in schizophrenia: a dissociation between the effects ofaversive and non-aversive stimuli

      SCHIZOPHRENIA RESEARCH
    27. Breier, A; Lieberman, JA
      New antipsychotic drugs: Special issues and indications - Introduction

      SCHIZOPHRENIA RESEARCH
    28. Breier, A; Su, TP; Malhotra, AK; Elman, I; Adler, CM; Weisenfeld, NI; Pickar, D
      Effects of atypical antipsychotic drug treatment on amphetamine-induced striatal dopamine release in patients with psychotic disorders

      NEUROPSYCHOPHARMACOLOGY
    29. ELMAN I; GOLDSTEIN DS; EISENHOFER G; FOLIO J; MALHOTRA AK; ADLER CM; PICKAR D; BREIER A
      MECHANISM OF PERIPHERAL NORADRENERGIC STIMULATION BY CLOZAPINE

      Neuropsychopharmacology
    30. Kubin, T; Ando, H; Scholz, D; Bramlage, P; Kostin, S; van Veen, A; Heling, A; Hein, S; Fischer, S; Breier, A; Schaper, J; Schaper, W
      Microvascular endothelial cells remodel cultured adult cardiomyocytes and increase their survival

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    31. Breier, A
      Notes on the reform of scientific work assessment systems in post-communist countries

      GENERAL PHYSIOLOGY AND BIOPHYSICS
    32. Barancik, M; Bohacova, V; Zbynovcova, M; Breier, A
      Differential expression of regulatory proteins in L1210/VCR cells with multidrug resistance mediated by P-glycoprotein

      GENERAL PHYSIOLOGY AND BIOPHYSICS
    33. Breier, A
      Cognitive deficit in schizophrenia and its neurochemical basis

      BRITISH JOURNAL OF PSYCHIATRY
    34. Elman, I; Sokoloff, L; Adler, CM; Weisenfeld, N; Breier, A
      The effects of pharmacological doses of 2-deoxyglucose on cerebral blood flow in healthy volunteers

      BRAIN RESEARCH
    35. Breier, A; Berg, PH
      The psychosis of schizophrenia: Prevalence, response to atypical antipsychotics, and prediction of outcome

      BIOLOGICAL PSYCHIATRY
    36. Breier, A; Hamilton, SH
      Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia

      BIOLOGICAL PSYCHIATRY
    37. Bryant, NL; Buchanan, RW; Vladar, K; Breier, A; Rothman, M
      Gender differences in temporal lobe structures of patients with schizophrenia: A volumetric MRI study

      AMERICAN JOURNAL OF PSYCHIATRY
    38. Adler, CM; Malhotra, AK; Elman, I; Goldberg, T; Egan, M; Pickar, D; Breier, A
      Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    39. OVA V; DOCOLOMANSKY P; BREIER A; GEMEINER P; ZIEGELHOFFER A
      INTERACTION OF LACTATE-DEHYDROGENASE WITH ANTHRAQUINONE DYES - CHARACTERIZATION OF LIGANDS FOR DYE-LIGAND CHROMATOGRAPHY

      Journal of chromatography B. Biomedical sciences and applications
    40. MALHOTRA AK; GOLDMAN D; MAZZANTI C; CLIFTON A; BREIER A; PICKAR D
      A FUNCTIONAL SEROTONIN TRANSPORTER (5-HTT) POLYMORPHISM IS ASSOCIATEDWITH PSYCHOSIS IN NEUROLEPTIC-FREE SCHIZOPHRENICS

      Molecular psychiatry
    41. MALHOTRA AK; GOLDMAN D; BUCHANAN RW; ROONEY W; CLIFTON A; KOSMIDIS MH; BREIER A; PICKAR D
      THE DOPAMINE D-3 RECEPTOR (DRD3) SER(9)GLY POLYMORPHISM AND SCHIZOPHRENIA - A HAPLOTYPE RELATIVE RISK STUDY AND ASSOCIATION WITH CLOZAPINE RESPONSE

      Molecular psychiatry
    42. PINALS DA; MALHOTRA AK; BREIER A; PICKAR D
      INFORMED CONSENT IN SCHIZOPHRENIA RESEARCH

      Psychiatric services
    43. ELMAN I; GOLDSTEIN DS; HOLMES C; PICKAR D; FOLIO J; ADLER C; BREIER A
      MECHANISM OF PERIPHERAL NORADRENERGIC STIMULATION BY CLOZAPINE

      Schizophrenia research
    44. DAVIC S; CRAWFORD AM; BREIER A
      PROLACTIN LEVELS IN OLANZAPINE VERSUS TYPICAL AND ATYPICAL ANTIPSYCHOTICS

      Schizophrenia research
    45. MALHOTRA AK; BREIER A; GOLDMAN D; PICKEN L; PICKAR D
      THE APOLIPOPROTEIN-E EPSILON-4 ALLELE IS ASSOCIATED WITH BLUNTING OF KETAMINE-INDUCED PSYCHOSIS IN SCHIZOPHRENIA - A PRELIMINARY-REPORT

      Neuropsychopharmacology
    46. BREIER A; ADLER CM; WEISENFELD N; SU TP; ELMAN I; PICKEN L; MALHOTRA AK; PICKAR D
      EFFECTS OF NMDA ANTAGONISM ON STRIATAL DOPAMINE RELEASE IN HEALTHY-SUBJECTS - APPLICATION OF A NOVEL PET APPROACH

      Synapse
    47. KVACKAJOVA J; BARTEKOVA M; BREIER A
      PURIFICATION OF S100-ALPHA PROTEIN FROM RAT SKELETAL-MUSCLE

      Chemicke zvesti
    48. ZBYNOVSKA D; BREIER A
      PREDICTION OF PROTEIN PARTITION IN AQUEOUS POLYETHYLENE-GLYCOL DEXTRAN 2-PHASE SYSTEM

      Chemicke zvesti
    49. BOHACOVA V; BREIER A; DOCOLOMANSKY P; GEMEINER P
      NUCLEOTIDE-BINDING SITES OF ENZYMES - TARGET OF THE INTERACTION WITH ANTHRAQUINONES

      Chemicke zvesti
    50. DOCOLOMANSKY P; POLEDNA J; BREIER A; GEMEINER P
      DETECTION OF ENZYME-ACTIVITY INHIBITION BY SUBSTRATE USING FLOW MICRO-CALORIMETER - ENZYME THERMISTOR

      Chemicke zvesti
    51. BREIER A; DROBNA Z; BOHACOVA V; BARANCIK M
      RESISTANCE OF L1210 MOUSE LEUKEMIC-CELL LINE CHARACTERIZED BY OVEREXPRESSION OF ATP-DEPENDENT DRUG TRANSPORTER TO SEVERAL DRUGS

      Chemicke zvesti
    52. BARANCIK M; BOHACOVA V; BREIER A
      POSSIBLE INVOLVEMENT OF MITOGEN-ACTIVATED PROTEIN-KINASES IN THE REGULATION OF P-GLYCOPROTEIN MEDIATED MULTIDRUG-RESISTANCE OF L1210 MOUSE LEUKEMIC-CELLS

      Chemicke zvesti
    53. DURICA M; BREIER A
      SYNTHESIS AND CHEMICAL-PROPERTIES OF DOXORUBICIN DERIVATES

      Chemicke zvesti
    54. Ziegelhoffer, A; Ravingerova, T; Volkovova, K; Dzurba, A; Breier, A; Vrbjar, N; Carsky, J; Waczulikova, I
      Regulation of Na,K-ATPase in the diabetic heart

      CHEMICAL PAPERS-CHEMICKE ZVESTI
    55. SULOVA Z; VYSKOCIL F; STANKOVICOVA T; BREIER A
      CA2-INDUCED INHIBITION OF SODIUM-PUMP - EFFECTS ON ENERGETIC METABOLISM OF MOUSE DIAPHRAGM TISSUE()

      General physiology and biophysics
    56. BREIER A; SULOVA Z; VRBANOVA A
      CA2-INDUCED INHIBITION OF SODIUM-PUMP - NONCOMPETITIVE INHIBITION IN RESPECT OF MAGNESIUM AND SODIUM-CATIONS()

      General physiology and biophysics
    57. MALHOTRA A; BUCHANAN R; BREIER A; PICKEN L; PICKAR D; GOLDMAN D
      ALLELIC VARIATION IN THE PROMOTER REGION OF THE DOPAMINE D-2 RECEPTORGENE INFLUENCES THE ANTIPSYCHOTIC RESPONSE TO CLOZAPINE

      American journal of medical genetics
    58. BREIER A; DROBNA Z; BARANCIK M
      DIRECT INTERACTION BETWEEN VERAPAMIL AND DOXORUBICIN CAUSES THE LACK OF REVERSAL EFFECT OF VERAPAMIL ON P-GLYCOPROTEIN MEDIATED RESISTANCE TO DOXORUBICIN IN-VITRO USING L1210 VCR CELLS/

      Neoplasma
    59. ADLER CM; MALHOTRA AK; GOLDBERG T; PICKAR D; BREIER A
      EFFECTS OF THE NMDA ANTAGONIST, KETAMINE ON FORMAL THOUGHT-DISORDER AND ON MEMORY IN HEALTHY-VOLUNTEERS

      Naunyn-Schmiedeberg's archives of pharmacology
    60. BERTOLINO A; CALLICOTT JH; ELMAN I; MATTAY VS; TEDESCHI G; FRANK JA; BREIER A; WEINBERGER DR
      REGIONALLY SPECIFIC NEURONAL PATHOLOGY IN UNTREATED PATIENTS WITH SCHIZOPHRENIA - A PROTON MAGNETIC-RESONANCE SPECTROSCOPIC IMAGING STUDY

      Biological psychiatry
    61. ADLER CM; GOLDBERG TE; MALHOTRA AK; PICKAR D; BREIER A
      EFFECTS OF KETAMINE ON THOUGHT-DISORDER, WORKING-MEMORY, AND SEMANTICMEMORY IN HEALTHY-VOLUNTEERS

      Biological psychiatry
    62. KRYSTAL JH; MOGHADDAM B; BREIER A; GOLDMANRAKIC P; MCELVEY J
      GLUTAMATE, DOPAMINE, THE FRONTAL-CORTEX, AND SCHIZOPHRENIA

      Biological psychiatry
    63. KAPUR S; SEEMAN P; JOYCE J; LARUELLE M; BREIER A
      THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA - ALIVE, WELL AND MOVING AHEAD

      Biological psychiatry
    64. ADLER CM; MALHOTRA AK; GOLDBERG T; ELMAN I; PICKAR D; BREIER A
      COMPARISON OF KETAMINE-INDUCED AND SCHIZOPHRENIC THOUGHT-DISORDER

      Biological psychiatry
    65. ELMAN I; GASTFRIEND DR; ADLER CM; MALHOTRA AK; BIR C; PICKAR D; BREIER A
      EFFECTS OF ACUTE METABOLIC STRESS ON PITUITARY-ADRENAL AXIS ACTIVATION IN PATIENTS WITH SCHIZOPHRENIA

      Biological psychiatry
    66. SU TP; PICKAR D; BREIER A
      DEXTROAMPHETAMINE-INDUCED NEUROCHEMICAL EFFECTS IN CHRONIC-SCHIZOPHRENICS AND HEALTHY-VOLUNTEERS

      Biological psychiatry
    67. ELMAN I; ADLER CM; MALHOTRA AK; BIR C; PICKAR D; BREIER A
      EFFECT OF ACUTE METABOLIC STRESS ON PITUITARY-ADRENAL AXIS ACTIVATIONIN PATIENTS WITH SCHIZOPHRENIA

      The American journal of psychiatry
    68. BUCHANAN RW; BREIER A; KIRKPATRICK B; BALL P; CARPENTER WT
      POSITIVE AND NEGATIVE SYMPTOM RESPONSE TO CLOZAPINE IN SCHIZOPHRENIC-PATIENTS WITH AND WITHOUT THE DEFICIT SYNDROME

      The American journal of psychiatry
    69. BREIER A; KESTLER L; ADLER C; ELMAN I; WIESENFELD N; MALHOTRA A; PICKAR D
      DOPAMINE D-2 RECEPTOR DENSITY AND PERSONAL DETACHMENT IN HEALTHY-SUBJECTS

      The American journal of psychiatry
    70. BUCHANAN RW; MALHOTRA A; KIRKPATRICK B; GOLDMAN D; BREIER A; PICKAR D
      LACK OF ASSOCIATION BETWEEN 5HT2A, 5HT2C, AND D4 RECEPTOR GENE POLYMORPHISMS AND THE DEFICIT SYNDROME OF SCHIZOPHRENIA

      Schizophrenia research
    71. BREIER A; SU TP; SAUNDERS R; CARSON RE; KOLACHANA BS; WEISENFELD N; MALHOTRA AK; ELMAN I; ECKELMAN WC; PICKAR D
      ASSESSMENT OF SYNAPTIC DOPAMINE CONCENTRATIONS IN SCHIZOPHRENIA WITH PET

      Schizophrenia research
    72. ELMAN I; GOLDSTEIN DS; HOLMES C; ADLER C; PICKAR D; BREIER A
      THE EFFECTS OF CLOZAPINE ON PLASMA NOREPINEPHRINE KINETICS IN SCHIZOPHRENIC-PATIENTS

      Schizophrenia research
    73. MALHOTRA AK; BREIER A; BUCHANAN R; GOLDMAN D; PICKAR D
      THE NMDA RECEPTOR AND SCHIZOPHRENIA - FROM PHENOTYPE TO GENOTYPE

      Schizophrenia research
    74. PICKAR D; GOLDMAN D; BUCHANAN R; BREIER A; MALHOTRA AK
      PREDICTING CLOZAPINE RESPONSE - SYSTEMATIC EVALUATION OF ALLELIC VARIATION IN CANDIDATE GENES

      Schizophrenia research
    75. WALTRIP RW; BUCHANAN RW; WILLIAM TC; KIRKPATRICK B; SUMMERFELT A; BREIER A; RUBIN SA; CARBONE KM
      BORNA-DISEASE VIRUS-ANTIBODIES AND THE DEFICIT SYNDROME OF SCHIZOPHRENIA

      Schizophrenia research
    76. MALHOTRA AK; PINALS DA; ADLER CM; ELMAN I; CLIFTON A; PICKAR D; BREIER A
      KETAMINE-INDUCED EXACERBATION OF PSYCHOTIC SYMPTOMS AND COGNITIVE IMPAIRMENT IN NEUROLEPTIC-FREE SCHIZOPHRENICS

      Neuropsychopharmacology
    77. ZIEGELHOFFER A; RAVINGEROVA T; STYK J; SEBOKOVA J; WACZULIKOVA I; BREIER A; DZURBA A; VOLKOVOVA K; CARSKY J; TURECKY L
      MECHANISMS THAT MAY BE INVOLVED IN CALCIUM TOLERANCE OF THE DIABETIC HEART

      Molecular and cellular biochemistry
    78. ENDRES CJ; KOLACHANA BS; SAUNDERS RC; SU T; WEINBERGER D; BREIER A; ECKELMAN WC; CARSON RE
      KINETIC MODELING OF [C-11] RACLOPRIDE - COMBINED PET-MICRODIALYSIS STUDIES

      Journal of cerebral blood flow and metabolism
    79. CARSON RE; BREIER A; DEBARTOLOMEIS A; SAUNDERS RC; SU TP; SCHMALL B; DER MG; PICKAR D; ECKELMAN WC
      QUANTIFICATION OF AMPHETAMINE-INDUCED CHANGES IN [C-11] RACLOPRIDE BINDING WITH CONTINUOUS-INFUSION

      Journal of cerebral blood flow and metabolism
    80. MALHOTRA AK; GOLDMAN D; MAZZANTI C; CLIFTON A; BREIER A; PICKAR D
      A FUNCTIONAL SEROTONIN TRANSPORTER POLYMORPHISM IS ASSOCIATED WITH PSYCHOSIS IN NEUROLEPTIC-FREE SCHIZOPHRENICS

      American journal of medical genetics
    81. PICKAR D; MALHOTRA AK; ROONEY W; BREIER A; GOLDMAN D
      APOLIPOPROTEIN-E EPSILON-4 AND CLINICAL PHENOTYPE IN SCHIZOPHRENIA

      Lancet
    82. MALHOTRA AK; GOLDMAN D; BUCHANAN R; PICKAR D; BREIER A
      THE ANTIPSYCHOTIC EFFICACY OF CLOZAPINE AND NMDA RECEPTOR FUNCTION - EVIDENCE FROM CLINICAL AND MOLECULAR STUDIES

      Psychopharmacology bulletin
    83. BREIER A; SU TP; SAUNDERS R; CARSON RE; KOLACHANA BS; DEBARTOLOMEIS A; WEINBERGER DR; WEISENFELD N; MALHOTRA AK; ECKELMAN WC; PICKAR D
      SCHIZOPHRENIA IS ASSOCIATED WITH ELEVATED AMPHETAMINE-INDUCED SYNAPTIC DOPAMINE CONCENTRATIONS - EVIDENCE FROM A NOVEL POSITRON EMISSION TOMOGRAPHY METHOD

      Proceedings of the National Academy of Sciences of the United Statesof America
    84. ELMAN I; BREIER A
      EFFECTS OF ACUTE METABOLIC STRESS ON PLASMA PROGESTERONE AND TESTOSTERONE IN MALE-SUBJECTS - RELATIONSHIP TO PITUITARY-ADRENOCORTICAL AXIS ACTIVATION

      Life sciences
    85. KIRKPATRICK B; LITMAN D; KIM JW; VLADAR K; BREIER A; BUCHANAN RW
      FAILURE OF FUSION OF THE SEPTUM PELLUCIDUM AND THE HETEROGENEITY OF SCHIZOPHRENIA

      The Journal of nervous and mental disease
    86. MALHOTRA AK; ADLER CM; KENNISON SD; ELMAN I; PICKAR D; BREIER A
      CLOZAPINE BLUNTS N-METHYL-D-ASPARTATE ANTAGONIST-INDUCED PSYCHOSIS - A STUDY WITH KETAMINE

      Biological psychiatry
    87. BERTOLINO A; ADLER C; CALLICOTT J; SANTHA A; PODELL D; MALHOTRA A; MATTAY V; PICKAR D; FRANK J; BREIER A; WEINBERGER DR
      EFFECTS OF KETAMINE ON WORKING-MEMORY CIRCUITRY AS STUDIED BY WHOLE-BRAIN FMRI

      Biological psychiatry
    88. ADLER CM; MALHOTRA AK; GOLDBERG T; ELMAN I; WEINBERGER D; PICKAR D; BREIER A
      EFFECTS OF THE NMDA ANTAGONIST, KETAMINE ON THOUGHT-DISORDER AND COGNITION

      Biological psychiatry
    89. MALHOTRA AK; ADLER CM; CLIFTON A; ELMAN I; PICKAR D; BREIER A
      CLOZAPINE BLUNTS NMDA ANTAGONIST-INDUCED PSYCHOSIS - A STUDY WITH KETAMINE

      Biological psychiatry
    90. ELMAN I; GOLDSTEIN DS; HOLMES C; PICKAR D; ADLER C; BREIER A
      CLOZAPINE-INDUCED ELEVATION IN NOREPINEPHRINE - RELATION TO ARTERIAL PLASMA SPILLOVER

      Biological psychiatry
    91. SU TP; MALHOTRA AK; HADD K; BREIER A; PICKAR D
      D-2 DOPAMINE-RECEPTOR OCCUPANCY - A CROSSOVER COMPARISON OF RISPERIDONE WITH CLOZAPINE THERAPY IN SCHIZOPHRENIC-PATIENTS

      Archives of general psychiatry
    92. BREIER A; MALHOTRA AK; PINALS DA; WEISENFELD NI; PICKAR D
      ASSOCIATION OF KETAMINE-INDUCED PSYCHOSIS WITH FOCAL ACTIVATION OF THE PREFRONTAL CORTEX IN HEALTHY-VOLUNTEERS

      The American journal of psychiatry
    93. LAFARGUE T; BREIER A
      NEURAL DEVELOPMENT AND SCHIZOPHRENIA - THEORY AND RESEARCH - MEDNICK,SA, HOLLISTER,JM

      The American journal of psychiatry
    94. BUCHANAN RW; STRAUSS ME; BREIER A; KIRKPATRICK B; CARPENTER WT
      ATTENTIONAL IMPAIRMENTS IN DEFICIT AND NONDEFICIT FORMS OF SCHIZOPHRENIA

      The American journal of psychiatry
    95. MALHOTRA AK; GOLDMAN D; OZAKI N; ROONEY W; CLIFTON A; BUCHANAN RW; BREIER A; PICKAR D
      CLOZAPINE RESPONSE AND THE 5HT(2C)CYS(23)SER POLYMORPHISM

      NeuroReport
    96. PINALS DA; MALHOTRA AK; MISSAR CD; PICKAR D; BREIER A
      LACK OF GENDER DIFFERENCES IN NEUROLEPTIC RESPONSE IN PATIENTS WITH SCHIZOPHRENIA

      Schizophrenia research
    97. MALHOTRA AK; PINALS DA; WEINGARTNER H; SIROCCO K; MISSAR CD; PICKAR D; BREIER A
      NMDA RECEPTOR FUNCTION AND HUMAN COGNITION - THE EFFECTS OF KETAMINE IN HEALTHY-VOLUNTEERS

      Neuropsychopharmacology
    98. BREIER A; ZIEGELHOFFER A; FAMULSKY K; MICHALAK M; SLEZAK J
      IS CYSTEINE RESIDUE IMPORTANT IN FITC-SENSITIVE ATP-BINDING SITE OF P-TYPE ATPASES - A COMMENTARY TO THE STATE-OF-THE-ART

      Molecular and cellular biochemistry
    99. ZIEGELHOFFER A; RAVINGEROVA T; DZURBA A; TRIBULOVA N; SLEZAK J; BREIER A; SZEKERES L
      PREVENTION BY 7-OXO-PROSTACYCLIN OF THE CALCIUM PARADOX IN RAT-HEART - ROLE OF THE SARCOLEMMAL (NA,K)-ATPASE

      Molecular and cellular biochemistry
    100. BREIER A; VRBANOVA A; DOCOLOMANSKY P; BOHACOVA V; ZIEGELHOFFER A
      COMPETITIVE-INHIBITION OF (NA K)-ATPASE BY FURYLETHYLENES WITH RESPECT TO POTASSIUM-IONS/

      General physiology and biophysics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/02/20 alle ore 16:28:33